Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Germ cell-specific gene 1-like protein 2 (GSG1L2) is a protein-coding gene located on human chromosome 17p13.1. The protein is predicted to localize to the plasma membrane but its precise molecular function remains uncharacterized as of current knowledge. It is a paralog of GSG1L, which is implicated in AMPA receptor modulation, but GSG1L2 itself has not been directly linked to such receptor or channel activity. Disease annotations exist for rare syndromic disorders, though its mechanistic role is undefined. There are currently no reported drugs, clinical biomarkers, or specific therapeutic safety concerns for this protein. GSG1L2 is best classified as a putative or uncharacterized membrane protein with unknown function and no demonstrated therapeutic target relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germ cell-specific gene 1-like protein 2 (GSG1L2).